← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Neurano Bioscience
La Jolla, CA
$3,909,598
Total funding
4
Grants
Funding over time
peak $1M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,909,598 · 4
By mechanism
R44$2,484,468 · 1
R43$1,425,130 · 3
Investigators at Neurano Bioscience
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic NMDA receptors for the treatment of opioid use disorder$837,882
R44 · FY2024 · DA
Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic NMDA receptors for the treatment of opioid use disorder$835,697
R44 · FY2023 · DA
Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic NMDA receptors for the treatment of opioid use disorder$810,889
R44 · FY2025 · DA
Pre-Clinical Evaluation of a Rationally Designed Nanotherapeutic for Huntington's Disease$518,505
R43 · FY2021 · NS
Alzheimer's disease and novel nanotherapeutics exclusively targeting extrasynaptic NMDA receptors$500,000
R43 · FY2021 · AG
Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic NMDA receptors for treatment of opioid use disorders$349,999
R43 · FY2019 · DA
Alzheimer's disease and novel nanotherapeutics exclusively targeting extrasynaptic NMDA receptors$56,626
R43 · FY2022 · AG